Phillip D. Stricker

13.3k total citations · 1 hit paper
187 papers, 8.2k citations indexed

About

Phillip D. Stricker is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Phillip D. Stricker has authored 187 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pulmonary and Respiratory Medicine, 41 papers in Rheumatology and 31 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Phillip D. Stricker's work include Prostate Cancer Treatment and Research (106 papers), Prostate Cancer Diagnosis and Treatment (104 papers) and Urologic and reproductive health conditions (34 papers). Phillip D. Stricker is often cited by papers focused on Prostate Cancer Treatment and Research (106 papers), Prostate Cancer Diagnosis and Treatment (104 papers) and Urologic and reproductive health conditions (34 papers). Phillip D. Stricker collaborates with scholars based in Australia, Netherlands and United States. Phillip D. Stricker's co-authors include Warick Delprado, Louise Emmett, Pim J. van Leeuwen, James Thompson, Phillip Brenner, Anne‐Maree Haynes, Bao Ho, Susan M. Henshall, Quoc Nguyen and Robert L. Sutherland and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Phillip D. Stricker

183 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Comparison of ¹⁸ F-Fluoromethylcholine Versus ⁶⁸ Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy

2015 438 citations Phillip D. Stricker, Pim J. van Leeuwen et al. Journal of Nuclear Medicine profile →

Peers

Countries citing papers authored by Phillip D. Stricker

Since Specialization

Citations

This map shows the geographic impact of Phillip D. Stricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip D. Stricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip D. Stricker more than expected).

Fields of papers citing papers by Phillip D. Stricker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip D. Stricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip D. Stricker. The network helps show where Phillip D. Stricker may publish in the future.

Co-authorship network of co-authors of Phillip D. Stricker

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip D. Stricker. A scholar is included among the top collaborators of Phillip D. Stricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip D. Stricker. Phillip D. Stricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling 2024 ·BMC Genomics ·Timothy J. Peters, (unknown), Lauren Ryan, Joanna Achinger-Kawecka, Jenny Z. Song, (unknown), Wenjia Qu, Shalima S. Nair, (unknown), Phillip D. Stricker, Elgene Lim, Clare Stirzaker, Susan J. Clark, Ruth Pidsley	15
2	Magnetic resonance guided adaptive post prostatectomy radiotherapy: Accumulated dose comparison of different workflows 2024 ·Journal of Applied Clinical Medical Physics ·(unknown), (unknown), Vikneswary Batumalai, (unknown), (unknown), Yuanyuan Ge, Phillip D. Stricker, Michael Jameson	2
3	Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐ IMMUNO study 2024 ·British Journal of Urology ·Bart Geboers, Matthijs J. Scheltema, Jason J. Jung, (unknown), Florentine E. F. Timmer, (unknown), (unknown), (unknown), (unknown), (unknown), Shikha Agrawal, Jayne Matthews, Anne‐Maree Haynes, (unknown), James Thompson, Martijn R. Meijerink, Susan J. Clark, Tanja D. de Gruijl, Phillip D. Stricker	4
4	The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities 2024 ·Scientific Reports ·(unknown), Riana Bornman, Phillip D. Stricker, Ilma Simoni Brum, Shingai B.A. Mutambirwa, Weerachai Jaratlerdsiri, Vanessa M. Hayes	1
5	Delphi Consensus Project on Prostate-specific Membrane Antigen (PSMA)-Targeted Surgery – outcomes from an international multidisciplinary panel 2023 ·European Urology Open Science ·(unknown), (unknown), Tobias Maurer, Katharina Hermann, Freddie C. Hamdy, Sophie Knipper, Paolo Dell’Oglio, Elio Mazzone, Hilda A. de Barros, Jonathan Sorger, Matthias N. van Oosterom, Phillip D. Stricker, Pim J. van Leeuwen, Daphne D. D. Rietbergen, R.A. Valdés Olmos, Sergi Vidal‐Sicart, Peter R. Carroll, Tessa Buckle, Henk G. van der Poel, Fijs W. B. van Leeuwen	2
6	Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy 2023 ·Pathology ·(unknown), (unknown), Zhixin Liu, (unknown), Anne‐Maree Haynes, Warick Delprado, Fiona Maclean, Carlo Yuen, Phillip D. Stricker, James Thompson	3
7	Delphi consensus project on prostate-specific membrane antigen (PSMA)–targeted surgery—outcomes from an international multidisciplinary panel 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Matthijs J. Scheltema, Tobias Maurer, (unknown), Freddie C. Hamdy, Sophie Knipper, Paolo Dell’Oglio, Elio Mazzone, Hilda A. de Barros, Jonathan Sorger, Matthias N. van Oosterom, Phillip D. Stricker, Pim J. van Leeuwen, Daphne D. D. Rietbergen, Renato A. Valdés Olmos, Sergi Vidal‐Sicart, Peter R. Carroll, Tessa Buckle, Henk G. van der Poel, Fijs W. B. van Leeuwen	6
8	The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer 2023 ·BMC Urology ·(unknown), (unknown), Matthijs J. Scheltema, Andrew Hayen, Amer Amin, Amila Siriwardana, (unknown), Bart Geboers, (unknown), (unknown), Jayne A. Matthews, Warick Delprado, Phillip D. Stricker, James Thompson	1
9	Artificial Intelligence‐Supported Video Analysis as a Means to Assess the Impact of DROP‐IN Image Guidance on Robotic Surgeons: Radioguided Sentinel Lymph Node versus PSMA‐Targeted Prostate Cancer Surgery 2023 ·SHILAP Revista de lepidopterología ·(unknown), Hilda A. de Barros, Daphne D. D. Rietbergen, Paolo Dell’Oglio, Pim J. van Leeuwen, Christian von Wagner, Phillip D. Stricker, Sergi Vidal‐Sicart, Alberto Briganti, Tobias Maurer, H.G. Van Der Poel, Matthias N. van Oosterom, Fijs W. B. van Leeuwen	8
10	The PRIMARY Score: Using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis. 2022 ·Journal of Nuclear Medicine ·Louise Emmett, Nathan Papa, James P Buteau, Bao Ho, Victor Liu, Matthew J. Roberts, James Thompson, Daniel Moon, Gemma Sheehan‐Dare, Omar Alghazo, Shikha Agrawal, Declan G. Murphy, Phillip D. Stricker, Thomas A. Hope, Michael S. Hofman	68
11	High prostate‐specific membrane antigen ( PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of significant prostate cancer 2022 ·British Journal of Urology ·(unknown), Nathan Papa, B.D. Kelly, James Thompson, Phillip D. Stricker, Matthew J. Roberts, Michael S. Hofman, James P Buteau, Declan G. Murphy, Louise Emmett, Daniel Moon	11
12	Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography ( PSMA‐PET) and magnetic resonance imaging ( MRI) to improve diagnosis of prostate cancer 2022 ·British Journal of Urology ·(unknown), (unknown), Nathan Papa, Gemma Sheehan‐Dare, Bao Ho, Jonathan Lee, Victor Liu, James Thompson, Shikha Agrawal, Matthew J. Roberts, James P Buteau, Michael S. Hofman, Daniel Moon, Nathan Lawrentschuk, Declan G. Murphy, Phillip D. Stricker, Louise Emmett	4
13	Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus? 2022 ·British Journal of Urology ·Sean Ong, (unknown), Jeremy Grummet, John Yaxley, Matthijs J. Scheltema, Phillip D. Stricker, Kae Jack Tay, Nathan Lawrentschuk	20
14	Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes 2022 ·BMC Urology ·Alexandar Blazevski, (unknown), Matthijs J. Scheltema, Amer Amin, Bart Geboers, (unknown), Anne‐Maree Haynes, Ron Shnier, Warick Delprado, Shikha Agrawal, James Thompson, Phillip D. Stricker	9
15	Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer 2020 ·British Journal of Urology ·Amer Amin, Alexandar Blazevski, James Thompson, Matthijs J. Scheltema, Michael S. Hofman, Declan G. Murphy, Nathan Lawrentschuk, Niranjan Sathianathen, Jada Kapoor, Henry H. Woo, Venu Chalasani, Krishan Rasiah, Pim J. van Leeuwen, Reuben Tang, Thomas W. Cusick, Phillip D. Stricker, Louise Emmett	45
16	The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis 2020 ·Cancers ·Megan Crumbaker, Eva K.F. Chan, Tingting Gong, Niall M. Corcoran, Weerachai Jaratlerdsiri, Ruth J. Lyons, Anne‐Maree Haynes, Anna Kulidjian, Anton M.F. Kalsbeek, Desiree C. Petersen, Phillip D. Stricker, Christina Jamieson, Peter I. Croucher, Christopher M. Hovens, Anthony M. Joshua, Vanessa M. Hayes	5
17	Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer 2018 ·Cancer Research ·Weerachai Jaratlerdsiri, Eva K.F. Chan, Tingting Gong, Desiree C. Petersen, Anton M.F. Kalsbeek, Philip A. Venter, Phillip D. Stricker, Riana Bornman, Vanessa M. Hayes	58
18	Enhancing active surveillance of prostate cancer: the potential of exercise medicine 2016 ·Nature Reviews Urology ·Daniel A. Galvão, Dennis R. Taaffe, Nigel Spry, Robert A. Gardiner, Renea A. Taylor, Gail P. Risbridger, Mark Frydenberg, Michelle M. Hill, Suzanne K. Chambers, Phillip D. Stricker, Tom Shannon, Dickon Hayne, Eva M. Zopf, Robert U. Newton	25
19	Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes 2015 ·BioMed Research International ·(unknown), Gerald B. Fogarty, Lauren E. Haydu, (unknown), Phillip D. Stricker	6
20	Androgen regulation of multidrug resistance‐associated protein 4 (MRP4/ABCC4) in prostate cancer 2008 ·The Prostate ·(unknown), James G. Kench, David J. Handelsman, George L. Scheffer, Phillip D. Stricker, (unknown), Robert L. Sutherland, Susan M. Henshall, John Allen, Lisa G. Horvath	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact